Physician profile
Mark G Moran
NPI 1023026622
$1,379.82
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $496 · 2020: $342 · 2021: $55.95 · 2022: $151 · 2023: $208 · 2024: $127.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $335.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $334.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $296.00 | 2019-2023 | Mini Trek |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $222.32 | 2019-2024 | Lifevest |
| Abiomed | $185.71 | 2022-2024 | Impella |
| Philips North America LLC | $171.17 | 2019-2021 | |
| Boston Scientific Corporation | $131.04 | 2019-2024 | Resonate El Icd Vr, Rotapro |
| Teleflex LLC | $109.35 | 2022-2024 | Guideliner, Vascband |
| Cardiovascular Systems INC. | $94.81 | 2020 | |
| Cardinal Health 200 LLC | $42.28 | 2019 | |
| Medtronic, INC. | $40.02 | 2022 | |
| Shockwave Medical, INC | $30.71 | 2019-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Opsens INC. | $26.30 | 2019 | |
| Medtronic Vascular, INC. | $19.10 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $11.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Moran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.